Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
辉瑞源自Metsera的每月给药GLP-1在六个月时将体重降低10.5%

Pfizer said Tuesday that the monthly injection that was one of the cornerstones of its $10 billion buyout of Metsera allowed obesity patients to lose up to 10.5% of their weight, on a placebo-adjusted basis, after just over six months.
辉瑞周二表示，在其以100亿美元收购Metsera的交易中作为基石之一的monthly injection，经安慰剂校正后，在稍超六个月时可帮助肥胖患者减重最多10.5%。